- Home
- ICUI vs PAM Comparison
ICUI vs PAM Comparison
Compare ICUI & PAM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ICUI
- PAM
- Stock Information
- Founded
- ICUI 1984
- PAM 1945
- Country
- ICUI United States
- PAM Argentina
- Employees
- ICUI N/A
- PAM N/A
- Industry
- ICUI Medical/Dental Instruments
- PAM Electric Utilities: Central
- Sector
- ICUI Health Care
- PAM Utilities
- Exchange
- ICUI Nasdaq
- PAM Nasdaq
- Market Cap
- ICUI 3.4B
- PAM 3.8B
- IPO Year
- ICUI 1992
- PAM N/A
- Fundamental
- Price
- ICUI $133.44
- PAM $68.81
- Analyst Decision
- ICUI Strong Buy
- PAM Buy
- Analyst Count
- ICUI 5
- PAM 3
- Target Price
- ICUI $196.75
- PAM $85.83
- AVG Volume (30 Days)
- ICUI 215.9K
- PAM 181.9K
- Earning Date
- ICUI 08-06-2025
- PAM 08-06-2025
- Dividend Yield
- ICUI N/A
- PAM N/A
- EPS Growth
- ICUI N/A
- PAM 32.60
- EPS
- ICUI N/A
- PAM 0.41
- Revenue
- ICUI $2,420,093,000.00
- PAM $1,970,436,590.00
- Revenue This Year
- ICUI N/A
- PAM $23.47
- Revenue Next Year
- ICUI N/A
- PAM $22.99
- P/E Ratio
- ICUI N/A
- PAM $6.92
- Revenue Growth
- ICUI 7.22
- PAM 21.62
- 52 Week Low
- ICUI $117.92
- PAM $38.58
- 52 Week High
- ICUI $196.26
- PAM $97.55
- Technical
- Relative Strength Index (RSI)
- ICUI 50.47
- PAM 42.70
- Support Level
- ICUI $129.26
- PAM $68.09
- Resistance Level
- ICUI $139.41
- PAM $75.40
- Average True Range (ATR)
- ICUI 4.24
- PAM 2.90
- MACD
- ICUI 0.53
- PAM 0.12
- Stochastic Oscillator
- ICUI 59.68
- PAM 16.99
About ICUI ICU Medical Inc.
ICU Medical is a California-based pure-play infusion therapy company that provides consumables, systems, and services for virtually every component of the IV continuum of care. ICU has become one of the largest players in its industry following its acquisition of Hospira Infusion Systems from Pfizer in 2017 and Smiths Medical from Smiths Group in 2022. It holds top-tier positions across its three reporting segments: consumables (43% of consolidated revenue), infusion systems (28%), and vital care (29%). The combined entity remains primarily US-focused, generating over 63% of its sales domestically.
About PAM Pampa Energia S.A.
Pampa Energia SA and its subsidiaries are engaged in the Energy business, mainly in oil and gas production and power generation. The firm's operating business segments are Oil and Gas, Generation, Petrochemicals, Holding, Transportation, and Others. The company derives the maximum revenue from the oil and gas segment.